Skin Models

20
May

APPLICATION NOTE – NativeSkin® & Pharma

Explore how NativeSkin® supports ethical, human-relevant, and translational research for pharma.

2
Apr

Advancing medical device development with ex vivo human skin

Advancing medical device development with ex vivo human skinMedical devices are evolving rapidly, becoming more sophisticated and diverse in their applications. From injectable drug delivery systems to wound dressings, wearable sensors, and microneedles, these innovations must undergo rigorous testing to ensure safety, functionality, and biocompatibility. However, as medical devices become more complex, so do the challenges associated with their preclinical
Read more
18
Mar

APPLICATION NOTE – NativeSkin® & Cosmetics

Explore how NativeSkin® supports human-relevant cosmetic efficacy and safety testing, helping you strengthen claims and de-risk formulations earlier.

13
Mar

Beyond animal models: The role of human skin in ADME testing

Beyond animal models: The role of human skin in ADME testingADME (Absorption, Distribution, Metabolism, and Excretion) testing plays a vital role in modern drug development by improving candidate selection, reducing failures, enhancing safety assessments, ensuring regulatory compliance, and ultimately saving time and resources in bringing new drugs to market. Traditionally, ADME testing has relied on animal models and in vitro
Read more
17
Feb

FACT SHEET – HairSkin, Human skin model with hair follicles

HairSkin®Human skin model with hair folliclesHairSkin®: the first ex vivo human skin model with mature pilosebaceous units HairSkin® is a cutting-edge ex vivo human skin model, developed with tissue containing fully mature pilosebaceous units. HairSkin® is designed to meet the requirements of both pharmaceutical and cosmetic industries and to empower innovation in dermatology, cosmetics, and personal care. Thanks to a
Read more
10
Feb

From human skin to human data: Advancing immunogenicity testing with human models

From human skin to human data: Advancing immunogenicity testing with human modelsIn a public workshop organized by the FDA-CRCG group, Dr. Nicolas Gaudenzio, CSO of Genoskin, introduced an innovative platform for assessing immune reactions in response to injected substances using human skin explants. His talk, titled "A new in vitro framework for assessing immunogenicity using comprehensive profiling of injectable human
Read more